-
1
-
-
77953894340
-
Clinical development and future direction for the treatment of hepatocellular carcinoma
-
Whang-Peng, J., Cheng, A.-L., Hsu, C., and Chen, C.-M. (2010) Clinical development and future direction for the treatment of hepatocellular carcinoma. J. Exp. Clin. Med. 2, 93-103
-
(2010)
J. Exp. Clin. Med
, vol.2
, pp. 93-103
-
-
Whang-Peng, J.1
Cheng, A.-L.2
Hsu, C.3
Chen, C.-M.4
-
2
-
-
79952724023
-
Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo
-
Rajendran, P., Ong, T. H., Chen, L., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Sharma, A., Kumar, A. P., Hui, K. M., and Sethi, G. (2011) Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin. Cancer Res. 17, 1425-1439
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 1425-1439
-
-
Rajendran, P.1
Ong, T.H.2
Chen, L.3
Li, F.4
Shanmugam, M.K.5
Vali, S.6
Abbasi, T.7
Kapoor, S.8
Sharma, A.9
Kumar, A.P.10
Hui, K.M.11
Sethi, G.12
-
3
-
-
84856429876
-
Obesity, inflammation, and liver cancer
-
Sun, B., and Karin, M. (2012) Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704-713
-
(2012)
J. Hepatol
, vol.56
, pp. 704-713
-
-
Sun, B.1
Karin, M.2
-
4
-
-
77953776656
-
Future perspectives in hepatocellular carcinoma
-
Wörns, M. A., and Galle, P. R. (2010) Future perspectives in hepatocellular carcinoma. Dig. Liver Dis. 42, S302-S309
-
(2010)
Dig. Liver Dis
, vol.42
, pp. S302-S309
-
-
Wörns, M.A.1
Galle, P.R.2
-
5
-
-
84866259297
-
Molecular mechanisms of liver injury and hepatocarcinogenesis: Focusing on the role of stress-activated MAPK
-
Nakagawa, H., and Maeda, S. (2012) Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Pathol. Res. Int. 2012, 172894
-
(2012)
Pathol. Res. Int
, vol.2012
, pp. 172894
-
-
Nakagawa, H.1
Maeda, S.2
-
6
-
-
33644778515
-
Hepatocellular carcinoma: Overcoming challenges in disease management
-
Gish, R. G. (2006) Hepatocellular carcinoma: overcoming challenges in disease management. Clin. Gastroenterol. Hepatol. 4, 252-261
-
(2006)
Clin. Gastroenterol. Hepatol
, vol.4
, pp. 252-261
-
-
Gish, R.G.1
-
7
-
-
33750985364
-
A new small-molecule Stat3 inhibitor
-
McMurray, J. S. (2006) A new small-molecule Stat3 inhibitor. Chem. Biol. 13, 1123-1124
-
(2006)
Chem. Biol
, vol.13
, pp. 1123-1124
-
-
McMurray, J.S.1
-
8
-
-
3543055012
-
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity
-
Turkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D., and Jove, R. (2004) Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 3, 261-269
-
(2004)
Mol. Cancer Ther
, vol.3
, pp. 261-269
-
-
Turkson, J.1
Kim, J.S.2
Zhang, S.3
Yuan, J.4
Huang, M.5
Glenn, M.6
Haura, E.7
Sebti, S.8
Hamilton, A.D.9
Jove, R.10
-
9
-
-
34247600538
-
STAT3 as a central mediator of neoplastic cellular transformation
-
Frank, D. A. (2007) STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 251, 199-210
-
(2007)
Cancer Lett
, vol.251
, pp. 199-210
-
-
Frank, D.A.1
-
10
-
-
33947417336
-
Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: Clinical implications
-
Huang, S. (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin. Cancer Res. 13, 1362-1366
-
(2007)
Clin. Cancer Res
, vol.13
, pp. 1362-1366
-
-
Huang, S.1
-
11
-
-
0036251154
-
Stat proteins and oncogenesis
-
Bromberg, J. (2002) Stat proteins and oncogenesis. J. Clin. Invest. 109, 1139-1142
-
(2002)
J. Clin. Invest
, vol.109
, pp. 1139-1142
-
-
Bromberg, J.1
-
12
-
-
0021086284
-
Synthesis of potential anticancer agents: Pyrido[4, 3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines
-
Temple, C., Jr., Wheeler, G. P., Comber, R. N., Elliott, R. D., and Montgomery, J. A. (1983) Synthesis of potential anticancer agents: pyrido[4, 3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines. J. Med. Chem. 26, 1614-1619
-
(1983)
J. Med. Chem
, vol.26
, pp. 1614-1619
-
-
Temple, C.1
Wheeler, G.P.2
Comber, R.N.3
Elliott, R.D.4
Montgomery, J.A.5
-
13
-
-
77956418569
-
A small oxazine compound as an anti-tumor agent: A novel pyranoside mimetic that binds to VEGF, HBEGF, and TNF-α
-
Basappa, Murugan, S., Kavitha, C. V., Purushothaman, A., Nevin, K. G., Sugahara, K., and Rangappa, K. S. (2010) A small oxazine compound as an anti-tumor agent: a novel pyranoside mimetic that binds to VEGF, HBEGF, and TNF-α. Cancer Lett. 297, 231-243
-
(2010)
Cancer Lett
, vol.297
, pp. 231-243
-
-
Basappa Murugan, S.1
Kavitha, C.V.2
Purushothaman, A.3
Nevin, K.G.4
Sugahara, K.5
Rangappa, K.S.6
-
14
-
-
84856076374
-
Preclinical characterization of atiprimod, a novel JAK2 and JAK3 inhibitor
-
Quintás-Cardama, A., Manshouri, T., Estrov, Z., Harris, D., Zhang, Y., Gaikwad, A., Kantarjian, H. M., and Verstovsek, S. (2011) Preclinical characterization of atiprimod, a novel JAK2 and JAK3 inhibitor. Invest. New Drugs 29, 818-826
-
(2011)
Invest. New Drugs
, vol.29
, pp. 818-826
-
-
Quintás-Cardama, A.1
Manshouri, T.2
Estrov, Z.3
Harris, D.4
Zhang, Y.5
Gaikwad, A.6
Kantarjian, H.M.7
Verstovsek, S.8
-
15
-
-
33846087418
-
Simplified staurosporine analogs as potent JAK3 inhibitors
-
Yang, S. M., Malaviya, R., Wilson, L. J., Argentieri, R., Chen, X., Yang, C., Wang, B., Cavender, D., and Murray, W. V. (2007) Simplified staurosporine analogs as potent JAK3 inhibitors. Bioorg. Med. Chem. Lett. 17, 326-331
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 326-331
-
-
Yang, S.M.1
Malaviya, R.2
Wilson, L.J.3
Argentieri, R.4
Chen, X.5
Yang, C.6
Wang, B.7
Cavender, D.8
Murray, W.V.9
-
17
-
-
23044478114
-
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells
-
Amit-Vazina, M., Shishodia, S., Harris, D., Van, Q., Wang, M., Weber, D., Alexanian, R., Talpaz, M., Aggarwal, B. B., and Estrov, Z. (2005) Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells. Br. J. Cancer 93, 70-80
-
(2005)
Br. J. Cancer
, vol.93
, pp. 70-80
-
-
Amit-Vazina, M.1
Shishodia, S.2
Van H. D, Q.3
Wang, M.4
Weber, D.5
Alexanian, R.6
Talpaz, M.7
Aggarwal, B.B.8
Estrov, Z.9
-
18
-
-
21144440687
-
Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo
-
Hamasaki, M., Hideshima, T., Tassone, P., Neri, P., Ishitsuka, K., Yasui, H., Shiraishi, N., Raje, N., Kumar, S., Picker, D. H., Jacob, G. S., Richardson, P. G., Munshi, N. C., and Anderson, K. C. (2005) Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo. Blood 105, 4470-4476
-
(2005)
Blood
, vol.105
, pp. 4470-4476
-
-
Hamasaki, M.1
Hideshima, T.2
Tassone, P.3
Neri, P.4
Ishitsuka, K.5
Yasui, H.6
Shiraishi, N.7
Raje, N.8
Kumar, S.9
Picker, D.H.10
Jacob, G.S.11
Richardson, P.G.12
Munshi, N.C.13
Anderson, K.C.14
-
19
-
-
66049104245
-
Synthetic staurosporines via a ring closing metathesis strategy as potent JAK3 inhibitors and modulators of allergic responses
-
Wilson, L. J., Malaviya, R., Yang, C., Argentieri, R., Wang, B., Chen, X., Murray, W. V., and Cavender, D. (2009) Synthetic staurosporines via a ring closing metathesis strategy as potent JAK3 inhibitors and modulators of allergic responses. Bioorg. Med. Chem. Lett. 19, 3333-3338
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 3333-3338
-
-
Wilson, L.J.1
Malaviya, R.2
Yang, C.3
Argentieri, R.4
Wang, B.5
Chen, X.6
Murray, W.V.7
Cavender, D.8
-
20
-
-
84892586858
-
Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors
-
Su, Q., Ioannidis, S., Chuaqui, C., Almeida, L., Alimzhanov, M., Bebernitz, G., Bell, K., Block, M., Howard, T., Huang, S., Huszar, D., Read, J. A., Rivard Costa, C., Shi, J., Su, M., Ye, M., and Zinda, M. (2014) Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors. J. Med. Chem. 57, 144-158
-
(2014)
J. Med. Chem
, vol.57
, pp. 144-158
-
-
Su, Q.1
Ioannidis, S.2
Chuaqui, C.3
Almeida, L.4
Alimzhanov, M.5
Bebernitz, G.6
Bell, K.7
Block, M.8
Howard, T.9
Huang, S.10
Huszar, D.11
Read, J.A.12
Rivard Costa, C.13
Shi, J.14
Su, M.15
Ye, M.16
Zinda, M.17
-
21
-
-
85064289101
-
Dysregulation of JAKSTAT pathway in hematological malignancies and JAK inhibitors for clinical application
-
Furqan, M., Mukhi, N., Lee, B., and Liu, D. (2013) Dysregulation of JAKSTAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomark. Res. 1, 5
-
(2013)
Biomark. Res
, vol.1
, pp. 5
-
-
Furqan, M.1
Mukhi, N.2
Lee, B.3
Liu, D.4
-
22
-
-
2442541062
-
Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride: (+/-) venlafaxine racemic mixtures
-
Basappa, Kavitha, C. V., and Rangappa, K. S. (2004) Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride: (+/-) venlafaxine racemic mixtures. Bioorg. Med. Chem. Lett. 14, 3279-3281
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 3279-3281
-
-
Basappa Kavitha, C.V.1
Rangappa, K.S.2
-
23
-
-
77955666853
-
Artemin reduces sensitivity to doxorubicin and paclitaxel in endometrial carcinoma cells through specific regulation of CD24
-
Pandey, V., Jung, Y., Kang, J., Steiner, M., Qian, P. X., Banerjee, A., Mitchell, M. D., Wu, Z. S., Zhu, T., Liu, D. X., and Lobie, P. E. (2010) Artemin reduces sensitivity to doxorubicin and paclitaxel in endometrial carcinoma cells through specific regulation of CD24. Transl. Oncol. 3, 218-229
-
(2010)
Transl. Oncol
, vol.3
, pp. 218-229
-
-
Pandey, V.1
Jung, Y.2
Kang, J.3
Steiner, M.4
Qian, P.X.5
Banerjee, A.6
Mitchell, M.D.7
Wu, Z.S.8
Zhu, T.9
Liu, D.X.10
Lobie, P.E.11
-
24
-
-
84910672931
-
Novel synthetic biscoumarins target tumor necrosis factor-α in hepatocellular carcinoma in vitro and in vivo
-
Keerthy, H. K., Mohan, C. D., Siveen, K. S., Fuchs, J. E., Rangappa, S., Sundaram, M. S., Li, F., Girish, K. S., Sethi, G., Basappa, Bender, A., and Rangappa, K. S. (2014) Novel synthetic biscoumarins target tumor necrosis factor-α in hepatocellular carcinoma in vitro and in vivo. J. Biol. Chem. 289, 31879-31890
-
(2014)
J. Biol. Chem
, vol.289
, pp. 31879-31890
-
-
Keerthy, H.K.1
Mohan, C.D.2
Siveen, K.S.3
Fuchs, J.E.4
Rangappa, S.5
Sundaram, M.S.6
Li, F.7
Girish, K.S.8
Sethi, G.9
Basappa Bender, A.10
Rangappa, K.S.11
-
25
-
-
84907486209
-
Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell lines
-
Keerthy, H. K., Garg, M., Mohan, C. D., Madan, V., Kanojia, D., Shobith, R., Nanjundaswamy, S., Mason, D. J., Bender, A., Basappa, Rangappa, K. S., and Koeffler, H. P. (2014) Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell lines. PloS One 9, e107118
-
(2014)
PloS One
, vol.9
, pp. e107118
-
-
Keerthy, H.K.1
Garg, M.2
Mohan, C.D.3
Madan, V.4
Kanojia, D.5
Shobith, R.6
Nanjundaswamy, S.7
Mason, D.J.8
Bender, A.9
Basappa10
Rangappa, K.S.11
Koeffler, H.P.12
-
26
-
-
84874638221
-
Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma
-
Manu, K. A., Shanmugam, M. K., Ong, T. H., Subramaniam, A., Siveen, K. S., Perumal, E., Samy, R. P., Bist, P., Lim, L. H., Kumar, A. P., Hui, K. M., and Sethi, G. (2013) Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma. PLoS One 8, e57015
-
(2013)
PLoS One
, vol.8
, pp. e57015
-
-
Manu, K.A.1
Shanmugam, M.K.2
Ong, T.H.3
Subramaniam, A.4
Siveen, K.S.5
Perumal, E.6
Samy, R.P.7
Bist, P.8
Lim, L.H.9
Kumar, A.P.10
Hui, K.M.11
Sethi, G.12
-
27
-
-
84907538651
-
Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR
-
Kumar, B., Paricharak, S., Dinesh, K., Siveen, K. S., Fuchs, J., Rangappa, S., Mohan, C. D., Mohandas, N., Kumar, A. P., and Sethi, G. (2014) Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-. RSC Adv. 4, 45143-45146
-
(2014)
RSC Adv
, vol.4
, pp. 45143-45146
-
-
Kumar, B.1
Paricharak, S.2
Dinesh, K.3
Siveen, K.S.4
Fuchs, J.5
Rangappa, S.6
Mohan, C.D.7
Mohandas, N.8
Kumar, A.P.9
Sethi, G.10
-
28
-
-
13344295097
-
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
-
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., and Roifman, C. M. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645-648
-
(1996)
Nature
, vol.379
, pp. 645-648
-
-
Meydan, N.1
Grunberger, T.2
Dadi, H.3
Shahar, M.4
Arpaia, E.5
Lapidot, Z.6
Leeder, J.S.7
Freedman, M.8
Cohen, A.9
Gazit, A.10
Levitzki, A.11
Roifman, C.M.12
-
29
-
-
84894080596
-
Neuronal activity-dependent STAT3 localization to nucleus is dependent on Tyr-705 and Ser-727 phosphorylation in rat hippocampal neurons
-
Murase, S., and McKay, R. D. (2014) Neuronal activity-dependent STAT3 localization to nucleus is dependent on Tyr-705 and Ser-727 phosphorylation in rat hippocampal neurons. Eur. J. Neurosci. 39, 557-565
-
(2014)
Eur. J. Neurosci
, vol.39
, pp. 557-565
-
-
Murase, S.1
McKay, R.D.2
-
30
-
-
0034658024
-
Serine phosphorylation of STATs
-
Decker, T., and Kovarik, P. (2000) Serine phosphorylation of STATs. Oncogene 19, 2628-2637
-
(2000)
Oncogene
, vol.19
, pp. 2628-2637
-
-
Decker, T.1
Kovarik, P.2
-
31
-
-
84883753799
-
Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma
-
Li, F., Shanmugam, M. K., Chen, L., Chatterjee, S., Basha, J., Kumar, A. P., Kundu, T. K., and Sethi, G. (2013) Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev. Res. 6, 843-854
-
(2013)
Cancer Prev. Res
, vol.6
, pp. 843-854
-
-
Li, F.1
Shanmugam, M.K.2
Chen, L.3
Chatterjee, S.4
Basha, J.5
Kumar, A.P.6
Kundu, T.K.7
Sethi, G.8
-
32
-
-
0030046753
-
STATs: Signal transducers and activators of transcription
-
Ihle, J. N. (1996) STATs: signal transducers and activators of transcription. Cell 84, 331-334
-
(1996)
Cell
, vol.84
, pp. 331-334
-
-
Ihle, J.N.1
-
33
-
-
0037160057
-
Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain
-
Schreiner, S. J., Schiavone, A. P., and Smithgall, T. E. (2002) Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J. Biol. Chem. 277, 45680-45687
-
(2002)
J. Biol. Chem
, vol.277
, pp. 45680-45687
-
-
Schreiner, S.J.1
Schiavone, A.P.2
Smithgall, T.E.3
-
34
-
-
84864835881
-
Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo
-
Rajendran, P., Li, F., Shanmugam, M. K., Kannaiyan, R., Goh, J. N., Wong, K. F., Wang, W., Khin, E., Tergaonkar, V., Kumar, A. P., Luk, J. M., and Sethi, G. (2012) Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev. Res. 5, 631-643
-
(2012)
Cancer Prev. Res
, vol.5
, pp. 631-643
-
-
Rajendran, P.1
Li, F.2
Shanmugam, M.K.3
Kannaiyan, R.4
Goh, J.N.5
Wong, K.F.6
Wang, W.7
Khin, E.8
Tergaonkar, V.9
Kumar, A.P.10
Luk, J.M.11
Sethi, G.12
-
35
-
-
0029069540
-
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
-
Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., and Jove, R. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83
-
(1995)
Science
, vol.269
, pp. 81-83
-
-
Yu, C.L.1
Meyer, D.J.2
Campbell, G.S.3
Larner, A.C.4
Carter-Su, C.5
Schwartz, J.6
Jove, R.7
-
36
-
-
80054764369
-
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again
-
Rosmorduc, O., and Desbois-Mouthon, C. (2011) Targeting STAT3 in hepatocellular carcinoma: sorafenib again. J. Hepatol. 55, 957-959
-
(2011)
J. Hepatol
, vol.55
, pp. 957-959
-
-
Rosmorduc, O.1
Desbois-Mouthon, C.2
-
37
-
-
43049147317
-
Interleukin-6 mediates G0/G1 growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway
-
Moran, D. M., Mattocks, M. A., Cahill, P. A., Koniaris, L. G., and McKillop, I. H. (2008) Interleukin-6 mediates G0/G1 growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J. Surg. Res. 147, 23-33
-
(2008)
J. Surg. Res
, vol.147
, pp. 23-33
-
-
Moran, D.M.1
Mattocks, M.A.2
Cahill, P.A.3
Koniaris, L.G.4
McKillop, I.H.5
-
38
-
-
0033166416
-
Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3
-
Zauberman, A., Zipori, D., Krupsky, M., and Ben-Levy, R. (1999) Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene 18, 3886-3893
-
(1999)
Oncogene
, vol.18
, pp. 3886-3893
-
-
Zauberman, A.1
Zipori, D.2
Krupsky, M.3
Ben-Levy, R.4
-
39
-
-
59449085264
-
Targeting inflammatory pathways for prevention and therapy of cancer: Short-term friend, long-term foe
-
Aggarwal, B. B., Vijayalekshmi, R. V., and Sung, B. (2009) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin. Cancer Res. 15, 425-430
-
(2009)
Clin. Cancer Res
, vol.15
, pp. 425-430
-
-
Aggarwal, B.B.1
Vijayalekshmi, R.V.2
Sung, B.3
-
40
-
-
79954459349
-
γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
-
Rajendran, P., Li, F., Manu, K. A., Shanmugam, M. K., Loo, S. Y., Kumar, A. P., and Sethi, G. (2011)γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent. Br. J. Pharmacol. 163, 283-298
-
(2011)
Br. J. Pharmacol
, vol.163
, pp. 283-298
-
-
Rajendran, P.1
Li, F.2
Manu, K.A.3
Shanmugam, M.K.4
Loo, S.Y.5
Kumar, A.P.6
Sethi, G.7
-
41
-
-
0033551699
-
Role of poly(ADP-ribose) polymerase (PARP) Cleavage in apoptosis: Caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells
-
Boulares, A. H., Yakovlev, A. G., Ivanova, V., Stoica, B. A., Wang, G., Iyer, S., and Smulson, M. (1999) Role of poly(ADP-ribose) polymerase (PARP) Cleavage in apoptosis: caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 274, 22932-22940
-
(1999)
J. Biol. Chem
, vol.274
, pp. 22932-22940
-
-
Boulares, A.H.1
Yakovlev, A.G.2
Ivanova, V.3
Stoica, B.A.4
Wang, G.5
Iyer, S.6
Smulson, M.7
-
42
-
-
33750632572
-
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
-
Han, Y., Amin, H. M., Franko, B., Frantz, C., Shi, X., and Lai, R. (2006) Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 108, 2796-2803
-
(2006)
Blood
, vol.108
, pp. 2796-2803
-
-
Han, Y.1
Amin, H.M.2
Franko, B.3
Frantz, C.4
Shi, X.5
Lai, R.6
-
43
-
-
81055140589
-
From in silico target prediction to multi-target drug design: Current databases, methods and applications
-
Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., and Bender, A. (2011) From in silico target prediction to multi-target drug design: current databases, methods and applications. J. Proteomics 74, 2554-2574
-
(2011)
J. Proteomics
, vol.74
, pp. 2554-2574
-
-
Koutsoukas, A.1
Simms, B.2
Kirchmair, J.3
Bond, P.J.4
Whitmore, A.V.5
Zimmer, S.6
Young, M.P.7
Jenkins, J.L.8
Glick, M.9
Glen, R.C.10
Bender, A.11
-
44
-
-
84883239935
-
In silico target predictions: Defining a benchmarking data set and comparison of performance of the multiclass Naive Bayes and Parzen-Rosenblatt window
-
Koutsoukas, A., Lowe, R., Kalantarmotamedi, Y., Mussa, H. Y., Klaffke, W., Mitchell, J. B., Glen, R. C., and Bender, A. (2013) In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naive Bayes and Parzen-Rosenblatt window. J. Chem. Inf. Model. 53, 1957-1966
-
(2013)
J. Chem. Inf. Model
, vol.53
, pp. 1957-1966
-
-
Koutsoukas, A.1
Lowe, R.2
Kalantarmotamedi, Y.3
Mussa, H.Y.4
Klaffke, W.5
Mitchell, J.B.6
Glen, R.C.7
Bender, A.8
-
45
-
-
0038322002
-
Cytosolic phospholipase A2 is an effector of Jak/STAT signaling and is involved in platelet-derived growth factor BB-induced growth in vascular smooth muscle cells
-
Yellaturu, C. R., and Rao, G. N. (2003) Cytosolic phospholipase A2 is an effector of Jak/STAT signaling and is involved in platelet-derived growth factor BB-induced growth in vascular smooth muscle cells. J. Biol. Chem. 278, 9986-9992
-
(2003)
J. Biol. Chem
, vol.278
, pp. 9986-9992
-
-
Yellaturu, C.R.1
Rao, G.N.2
-
46
-
-
77951018948
-
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
-
Hazan-Halevy, I., Harris, D., Liu, Z., Liu, J., Li, P., Chen, X., Shanker, S., Ferrajoli, A., Keating, M. J., and Estrov, Z. (2010) STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 115, 2852-2863
-
(2010)
Blood
, vol.115
, pp. 2852-2863
-
-
Hazan-Halevy, I.1
Harris, D.2
Liu, Z.3
Liu, J.4
Li, P.5
Chen, X.6
Shanker, S.7
Ferrajoli, A.8
Keating, M.J.9
Estrov, Z.10
-
47
-
-
0030744123
-
Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence onDNAbinding of Stat1 and Stat3
-
Wen, Z., and Darnell, J. E., Jr. (1997) Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence onDNAbinding of Stat1 and Stat3. Nucleic Acids Res. 25, 2062-2067
-
(1997)
Nucleic Acids Res
, vol.25
, pp. 2062-2067
-
-
Wen, Z.1
Darnell, E.J.2
-
48
-
-
84878116135
-
Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells
-
Nam, S., Wen, W., Schroeder, A., Herrmann, A., Yu, H., Cheng, X., Merz, K. H., Eisenbrand, G., Li, H., Yuan, Y. C., and Jove, R. (2013) Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells. Mol. Oncol. 7, 369-378
-
(2013)
Mol. Oncol
, vol.7
, pp. 369-378
-
-
Nam, S.1
Wen, W.2
Schroeder, A.3
Herrmann, A.4
Yu, H.5
Cheng, X.6
Merz, K.H.7
Eisenbrand, G.8
Li, H.9
Yuan, Y.C.10
Jove, R.11
-
49
-
-
31544458469
-
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells
-
Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., Yoder, S., Enkemann, S., Eschrich, S., Lee, J. H., Beam, C. A., Cheng, J., Minton, S., Muro-Cacho, C. A., and Jove, R. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res. 12, 11-19
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 11-19
-
-
Gritsko, T.1
Williams, A.2
Turkson, J.3
Kaneko, S.4
Bowman, T.5
Huang, M.6
Nam, S.7
Eweis, I.8
Diaz, N.9
Sullivan, D.10
Yoder, S.11
Enkemann, S.12
Eschrich, S.13
Lee, J.H.14
Beam, C.A.15
Cheng, J.16
Minton, S.17
Muro-Cacho, C.A.18
Jove, R.19
|